{"items":[{"entityInfo":{"id":"70","uuid":"c2fdebef-9ef1-4344-82e1-07cb67b9f7c8","type":"node","bundle":"news"},"actions":{"edit":"https:\/\/admin.ich.org\/node\/70\/edit"},"bundleInfo":{"title":"Call for Expression of Interest for ICH Training Associates","published":true,"created":"2019-05-03T14:12:44+0200","updated":"2019-05-03T14:33:25+0200","alias":"\/news\/call-expression-interest-ich-training-associates-1"},"summary":"ICH is conducting a Call for Expression of Interest for ICH Training Associates with a view to exploring the possibility of contracting appropriate accredited non-profit training organisations\/institutions","date":"2019-04-05T12:15:00+0200","mainWidgets":{"entityType":"paragraph","items":["393"]},"sidebarWidgets":[]},{"entityInfo":{"id":"93","uuid":"359fc0ae-d8b6-4e3e-990b-6935ec6783ba","type":"node","bundle":"news"},"actions":{"edit":"https:\/\/admin.ich.org\/node\/93\/edit"},"bundleInfo":{"title":"The ICH S9 Q\u0026As reaches Step 4 of the ICH Process","published":true,"created":"2019-05-03T15:46:51+0200","updated":"2019-05-03T15:47:30+0200","alias":"\/news\/ich-s9-qas-reaches-step-4-ich-process"},"summary":"The ICH S9 Q\u0026As on Nonclinical Evaluation for Anticancer Pharmaceuticals reached Step 4 of the ICH Process in April 2018 and now enters into the implementation period (Step 5).","date":"2018-04-30T13:45:00+0200","mainWidgets":{"entityType":"paragraph","items":["483"]},"sidebarWidgets":[]},{"entityInfo":{"id":"132","uuid":"0f77faa6-df9e-4a48-b336-3a8d308396b0","type":"node","bundle":"news"},"actions":{"edit":"https:\/\/admin.ich.org\/node\/132\/edit"},"bundleInfo":{"title":"New ICH M9 Guideline in development on Biopharmaceutics Classification System (BCS)-based biowaivers","published":true,"created":"2019-05-03T20:08:49+0200","updated":"2019-05-03T20:10:15+0200","alias":"\/news\/new-ich-m9-guideline-development-biopharmaceutics-classification-system-bcs-based-biowaivers"},"summary":"In October 2016, the ICH endorsed a new topic for the development of a new multidisciplinary guideline to address Biopharmaceutics Classification System (BCS)-based biowaivers. ","date":"2016-10-19T18:15:00+0200","mainWidgets":{"entityType":"paragraph","items":["563"]},"sidebarWidgets":[]},{"entityInfo":{"id":"145","uuid":"787bbab0-a72d-49d5-8209-a087533b9215","type":"node","bundle":"news"},"actions":{"edit":"https:\/\/admin.ich.org\/node\/145\/edit"},"bundleInfo":{"title":"ICH Information Day at the Euro DIA in Hambourg","published":true,"created":"2019-05-03T20:32:46+0200","updated":"2019-05-03T20:33:17+0200","alias":"\/news\/ich-information-day-euro-dia-hambourg"},"summary":"On 6 April 2016, the Drug Information Association (DIA) in collaboration with the European Commission (EC) and the European Medicines Agency (EMA) are organising an \u201cInformation Day on ICH\u201d. ","date":"2016-02-23T19:30:00+0100","mainWidgets":{"entityType":"paragraph","items":["589"]},"sidebarWidgets":[]},{"entityInfo":{"id":"146","uuid":"4de99547-83cc-4cfb-b6c7-7286d6f2ccb2","type":"node","bundle":"news"},"actions":{"edit":"https:\/\/admin.ich.org\/node\/146\/edit"},"bundleInfo":{"title":"Therapeutic Goods Administration (TGA) of Australia newest Observer","published":true,"created":"2019-05-03T20:34:26+0200","updated":"2019-05-03T20:34:55+0200","alias":"\/news\/therapeutic-goods-administration-tga-australia-newest-observer"},"summary":"ICH is pleased to welcome the Therapeutic Goods Administration (TGA) of Australia as its newest Observer.","date":"2016-01-13T19:30:00+0100","mainWidgets":{"entityType":"paragraph","items":["591"]},"sidebarWidgets":[]},{"entityInfo":{"id":"147","uuid":"e570db74-3a0e-4d1e-a219-fad9ba7075d6","type":"node","bundle":"news"},"actions":{"edit":"https:\/\/admin.ich.org\/node\/147\/edit"},"bundleInfo":{"title":"ICH Membership and Observership Application Process","published":true,"created":"2019-05-03T20:36:00+0200","updated":"2019-05-03T20:36:20+0200","alias":"\/news\/ich-membership-and-observership-application-process"},"summary":"The Membership and Observership Application Process is now available on the ICH website.","date":"2015-12-18T19:30:00+0100","mainWidgets":{"entityType":"paragraph","items":["593"]},"sidebarWidgets":[]},{"entityInfo":{"id":"160","uuid":"7d0e8eb1-b065-45ec-890b-8bacb4c67b57","type":"node","bundle":"news"},"actions":{"edit":"https:\/\/admin.ich.org\/node\/160\/edit"},"bundleInfo":{"title":"New audio presentation available online for ICH Q3D Guideline","published":true,"created":"2019-05-03T20:57:09+0200","updated":"2019-05-03T20:57:40+0200","alias":"\/news\/new-audio-presentation-available-online-ich-q3d-guideline"},"summary":"To facilitate the implementation of ICH Guidelines and other documents, the ICH website gets updated regularly with new training material. ","date":"2015-06-17T19:00:00+0200","mainWidgets":{"entityType":"paragraph","items":["619"]},"sidebarWidgets":[]},{"entityInfo":{"id":"164","uuid":"53243109-ff3f-4370-8bae-565fbdb9ad7e","type":"node","bundle":"news"},"actions":{"edit":"https:\/\/admin.ich.org\/node\/164\/edit"},"bundleInfo":{"title":"ICH Information Day at the Euro DIA in Paris","published":true,"created":"2019-05-03T21:02:35+0200","updated":"2019-05-03T21:03:04+0200","alias":"\/news\/ich-information-day-euro-dia-paris"},"summary":"On 13 April 2015, the Drug Information Association (DIA) in collaboration with the European Commission (EC) and the European Medicines Agency (EMA) are organising an \u201cInformation Day on ICH\u201d.","date":"2015-02-19T20:00:00+0100","mainWidgets":{"entityType":"paragraph","items":["627"]},"sidebarWidgets":[]},{"entityInfo":{"id":"167","uuid":"a3a1c92e-e5e5-4dff-a35b-0a46f5699188","type":"node","bundle":"news"},"actions":{"edit":"https:\/\/admin.ich.org\/node\/167\/edit"},"bundleInfo":{"title":"ICH E2B(R3) Q\u0026As available on the ICH ESTRI website","published":true,"created":"2019-05-03T21:06:37+0200","updated":"2019-05-03T21:07:21+0200","alias":"\/news\/ich-e2br3-qas-available-ich-estri-website"},"summary":"In November 2014, the ICH E2B(R3) Implementation Working Group finalised under Step 4 of the ICH Process a set of Questions and Answers which intends to clarify specific issues identified since the ICH E2B(R3) Guideline was published in the ICH Regions.","date":"2015-01-29T20:00:00+0100","mainWidgets":{"entityType":"paragraph","items":["633"]},"sidebarWidgets":[]},{"entityInfo":{"id":"181","uuid":"8b275f29-50ad-4713-9fec-306c990192d3","type":"node","bundle":"news"},"actions":{"edit":"https:\/\/admin.ich.org\/node\/181\/edit"},"bundleInfo":{"title":"ICH Information Day at the Euro DIA","published":true,"created":"2019-05-03T22:24:52+0200","updated":"2019-05-03T22:25:14+0200","alias":"\/news\/ich-information-day-euro-dia"},"summary":"On 28 March 2014, DIA and EFPIA (one of the funding member of ICH) are organising an \u201cInformation Day on ICH\u201d to provide an update on the status of active topics and potential new topics to be harmonised.","date":"2014-02-10T21:30:00+0100","mainWidgets":{"entityType":"paragraph","items":["661"]},"sidebarWidgets":[]}],"_meta":{"maxCount":324,"limit":10,"offset":0}}